Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Urticaria
ADR ID BADD_A04469
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.06      Urticarias
10.01.06.001      Urticaria
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.02      Urticarias
23.04.02.001      Urticaria
Description A disorder characterized by an itchy skin eruption characterized by wheals with pale interiors and well-defined red margins. [CTCAE] A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. [MeSH]
MedDRA Code 10046735
MeSH ID D014581
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute allergic urticaria | Acute urticaria | Allergic urticaria | Erythema urticarial | Generalised urticarial | Generalised urticarial rash | Histamine-like rash | Hives | Nettle rash | Other specified urticaria | Pharmacological urticaria | Rash urticaria-like | Rash urticarial | Subcutaneous urticaria | Unspecified urticaria | Urticaria | Urticaria acute | Urticaria aggravated | Urticaria NOS | Urticaria subcutaneous | Urticaria, unspecified | Urticarial | Urticarial rash | Urticarial symptom | Urticated rash | Urtication | Welts | Wheals | Generalized urticaria | Urticaria generalised | Urticaria drug-induced | Urticaria localised | Urticaria localized | Generalized urticarial rash | Urticaria recurrent | Generalised urticaria | Atopic urticaria | Urticarias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00181Atomoxetine hydrochloride--
BADD_D00182Atorvastatin calcium--
BADD_D00183Atorvastatin calcium propylene glycol--
BADD_D00184Atorvastatin calcium trihydrate--
BADD_D00186Atovaquone0.000213%
BADD_D00187Atracurium--
BADD_D00188Atracurium besylate--
BADD_D00189Atropine--
BADD_D00191Auranofin--
BADD_D00194Azacitidine--
BADD_D00197Azelaic acid0.001668%
BADD_D00203Azithromycin0.000429%
BADD_D00204Azithromycin dihydrate--
BADD_D00205Azithromycin monohydrate--
BADD_D00206Aztreonam0.000131%
BADD_D00209Baclofen--
BADD_D00213Barium sulfate--
BADD_D00214Basiliximab--
BADD_D00215Bazedoxifene acetate--
BADD_D00217Beclomethasone--
BADD_D00218Beclomethasone 17-monopropionate--
BADD_D00219Beclomethasone dipropionate0.000243%
BADD_D00220Beclomethasone dipropionate monohydrate--
BADD_D00226Benaphetamine--
BADD_D00230Bendamustine0.001019%
BADD_D00232Bendroflumethiazide--
BADD_D00233Benicar hydrochlorothiazide--
BADD_D00235Benzalkonium chloride--
BADD_D00237Benzocaine--
BADD_D00241Benzoyl peroxide0.000599%
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 45 Pages
ADReCS-Target
ADR Term Drug Name Target